The Europe Artificial Intelligence (AI) in Medical Diagnostics Market would witness market growth of 38.8% CAGR during the forecast period (2022-2028).
The primary application of artificial intelligence in healthcare is to evaluate the link between treatment strategies and patient outcomes. In medical operations such as diagnostic procedures, drug research, tailored medications, and patient monitoring, AI applications are utilized. For instance, AI could assist in clinical procedures by monitoring vital signs, asking patients questions, and providing medicines. During medical procedures, AI systems can also be utilized for alerts and reminders, information retrieval, picture interpretation, and therapeutic planning. Deep learning is the most popular form of AI technology and is used for image identification, signal recognition, and data mining.
Applications of artificial intelligence range from image collecting and processing to assisted reporting, follow-up strategies, data storage, and data mining. The use of machine learning combines computational models and techniques that replicate the architecture of the brain's biological neural network, i.e. artificial neural networks. Performance-wise Traditional machine learning has a lower performance rate than deep learning.
The German healthcare market offers diverse opportunities along the value supply chain route, including Design, research and development collaboration, strategic partnerships, equity partner and investor engagements, mergers and acquisitions, project collaboration, and other opportunities for small and medium-sized enterprises (SMEs) to grow their businesses and expand their market presence. The objective is for faster diagnostics and treatments to help save expenses and provide clients with more timely and accurate care. Furthermore, the integration of AI in healthcare technologies is estimated to be fueled due to this. Hence, this factor would bolster the growth of regional AI in the medical diagnosis market.
The Germany market dominated the Europe Artificial Intelligence (AI) in Medical Diagnostics Market by Country in 2021; thereby, achieving a market value of $490.5 million by 2028. The UK market is exhibiting a CAGR of 37.6% during (2022 - 2028). Additionally, The France market would experience a CAGR of 39.8% during (2022 - 2028).
Based on Application, the market is segmented into In Vivo Diagnostics and In Vitro Diagnostics. Based on Vivo Diagnostics Specialty Type, the market is segmented into Radiology, Cardiology, Neurology, Obstetrics/gynecology, Ophthalmology and Others. Based on Vivo Diagnostics Modality Type, the market is segmented into Computed Tomography, X-Ray & Ultrasound, Magnetic Resonance Imaging and Others. Based on End User, the market is segmented into In Hospitals, Diagnostics Imaging Centers, Diagnostics Laboratories and Others. Based on Component, the market is segmented into Services and Software. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Artificial Intelligence (AI) in Medical Diagnostics Market will Hit $7.3 Billion by 2028, at a CAGR of 39.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Microsoft Corporation, Nvidia Corporation, IBM Corporation, Intel Corporation, Google LLC, Siemens Healthineers AG (Siemens AG), General Electric (GE) Co. (GE Healthcare), Xilinx, Inc., Digital Diagnostics, Inc. and InformAI, LLC
By Application
By End User
By Component
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
